Autism Spectrum Disorder
📧 Sign up to get email alerts when something new happens for Autism Spectrum Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism [Phase 4]
Phase 4 trial evaluating lisdexamfetamine for safety and effect in children with ADHD and autism spectrum disorder has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder [Phase 2]
Phase 2 pilot study of IGF-1 in autism spectrum disorder has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Treatment of Encopresis in Children With Autism Spectrum Disorders [Phase 3]
Phase 3 clinical trial evaluating treatment for encopresis in children with autism spectrum disorders has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Providing Accessible Diagnostic Evaluations and Psychoeducation for Autism Spectrum Disorder in Rural Southwest Virginia [NA]
A completed clinical trial evaluating accessible diagnostic evaluations and psychoeducation for autism spectrum disorder in rural Southwest …
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT [Phase 4]
Phase 4 clinical trial update focusing on safety and pharmacokinetics of antipsychotics in children with autism spectrum disorder, exploring…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-12-05FDA Approved: RISPERIDONE — Original Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva Pharmaceuticals' generic risperidone as an original application (ANDA214068).
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: Specifying and Treating Anxiety in Autism Research [Phase 2]
Phase 2 clinical trial update investigating specification and treatment of anxiety in autism.
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: The Effect of Play on Social and Motor Skills of Children With ASD [NA]
A completed clinical trial examining how play impacts social and motor skills in children with Autism Spectrum Disorder; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Double Blind Trial in Children With Autism Spectrum Disorder [Phase 2]
A Phase 2 double-blind clinical trial in children with Autism Spectrum Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Mindfulness for Parents of Children With Autism Spectrum Disorder Autism Spectrum Disorder [NA]
A completed clinical trial investigating mindfulness for parents of children with autism spectrum disorder; results posted in 2023.
-
FDA approval · 2023-11-01FDA Approved: ARIPIPRAZOLE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic oral aripiprazole under an original ANDA.
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders [NA]
Open-label trial evaluating oxytocin in adolescents with autism spectrum disorders; the study is completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Cognoa Autism Spectrum Disorder (ASD) Digital Therapeutic Engagement and Usability Study [NA]
Clinical trial update for Cognoa's ASD digital therapeutic engagement and usability study; study terminated with results posted.
-
FDA approval · 2023-09-18FDA Approved: RISPERIDONE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved a supplemental application for risperidone by Jubilant Cadista Pharmaceuticals Inc., updating/expanding its approval for risper…
-
CLINICAL_TRIALS trial_result · 2023-08-16Clinical Trial Update: A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder [Phase 3]
A Phase 3 clinical trial evaluating oxytocin for social impairment in individuals with high-functioning autism spectrum disorder has complet…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Screening for Autism Spectrum Disorders Using Auditory Brainstem Responses
A completed clinical trial evaluating the use of auditory brainstem responses as a screening tool for autism spectrum disorders.
-
FDA approval · 2023-08-08FDA Approved: RISPERIDONE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for risperidone from Aurobindo Pharma Limited, authorizing a generic risperidone product under ANDA …
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Photobiomodulation in Autism Spectrum Disorder (ASD) [NA]
A completed clinical trial evaluating photobiomodulation therapy for autism spectrum disorder has posted results in July 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Proof of Mechanism Study for the Treatment of Social Anhedonia in ASD [Phase 2]
Phase 2 proof-of-mechanism study investigating a treatment for social anhedonia in autism spectrum disorder (ASD).
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Daily Living Skills Intervention for 9th and 10th Graders With Autism Spectrum Disorders [NA]
A completed clinical trial evaluating a daily living skills intervention for 9th and 10th graders with autism spectrum disorder; results pos…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Modifying (Phase I) and Evaluating (Phase II) Virtual Reality Job Interview Training for Youth in Transition [NA]
Phase I/II trial update on virtual reality job interview training for youth with autism; study completed with posted results.
-
FDA approval · 2023-06-15FDA Approved: ARIPIPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for aripiprazole from Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Changing Developmental Trajectories Through Early Treatment [NA]
Clinical trial for autism spectrum disorders was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder. [Phase 3]
A phase 3 trial evaluating the efficacy and safety of an oral liquid formulation of bumetanide in children aged 2 to less than 7 with autism…
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Video Assisted Speech Technology to Enhance Motor Planning for Speech [NA]
Completed clinical trial evaluating video-assisted speech technology to enhance motor planning for speech in autism spectrum disorder and ap…